• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ALNOV:FP

4.3200 EUR 0.1800 4.00%

As of 07:37:38 ET on 01/27/2015.

Snapshot for Novacyt (ALNOV)

Open: 4.4900 Day's Range: 4.3200 - 4.5000 Volume: 771
Previous Close: 4.5000 52wk Range: 4.0000 - 7.4500 1-Yr Rtn: -31.54%

Stock Chart for ALNOV

No chart data available.
  • ALNOV:FP 4.3300
  • 1D
  • 1M
  • 1Y
4.5000
Interactive ALNOV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALNOV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -0.3550
Est. EPS (EUR) (12/2014) -0.5600
Est. PEG Ratio -
Market Cap (M EUR) 28.22
Shares Outstanding (M) 6.27
30 Day Average Volume 1,173
Price/Book (mrq) -
Price/Sale (ttm) 10.4743
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/02/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALNOV

No data available

Company Profile & Key Executives for ALNOV

Novacyt has developed and commercializes a cancer screening solution in the field of liquid based cytology.

Eric PeltierChairman/CEO/Co-FounderJean-Pierre CrinelliCOO/Co-Founder
More Company Profile & Key Executives for ALNOV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil